首页> 外文期刊>Bioorganic and medicinal chemistry >Development and characterization of a Ga-68-labeled A20FMDV2 peptide probe for the PET imaging of alpha v beta 36 integrin-positive pancreatic ductal adenocarcinoma
【24h】

Development and characterization of a Ga-68-labeled A20FMDV2 peptide probe for the PET imaging of alpha v beta 36 integrin-positive pancreatic ductal adenocarcinoma

机译:α-68标记的A20FMDV2肽探针的开发和表征用于αvβ36整合蛋白正胰腺导管腺癌的PET成像

获取原文
获取原文并翻译 | 示例
           

摘要

Pancreatic ductal adenocarcinoma (PDAC) is known to be one of the most lethal cancers. Since the majority of patients are diagnosed at an advanced stage, development of a detection method for PDAC at an earlier stage of disease progression is strongly desirable. Integrin alpha(V)beta 6 is a promising target for early PDAC detection because its expression increases during precancerous changes. The present study aimed to develop an imaging probe for positron emission tomography (PET) which targets alpha(V)beta 6 integrin-positive PDAC. We selected A20FMDV2 peptide, which binds specifically to alpha V beta 6 integrin, as a probe scaffold, and Ga-68 as a radioisotope. A20FMDV2 peptide has not been previously labeled with Ga-68. A cysteine residue was introduced to the N-terminus of the probe at a site-specific conjugation of maleimide-NOTA (mal-NOTA) chelate. Different numbers of glycine residues were also introduced between cysteine and the A20FMDV2 sequence as a spacer in order to reduce the steric hindrance of the mal-NOTA on the binding probe to alpha V beta 6 integrin. In vitro, the competitive binding assay revealed that probes containing a 6-glycine linker ([Ga-nat]CG6 and [Ga-nat]Ac-CG6) showed high affinity to alpha V beta 6 integrin. Both probes could be labeled by Ga-67/68 with high radiochemical yield (>50%) and purity (>98%). On biodistribution analysis, [Ga-67]Ac-CG6 showed higher tumor accumulation, faster blood clearance, and lower accumulation in the surrounding organs of pancreas than did [Ga-67]CG6. The alpha(v)beta 6 integrin-positive xenografts were clearly visualized by PET imaging with [Ga-68]Ac-CG6. The intratumoral distribution of [Ga-68]Ac-CG6 coincided with the alpha(v)beta 6 integrin-positive regions detected by immunohistochemistry. Thus, [Ga-68]Ac-CG6 is a useful peptide probe for the imaging of alpha(v)beta 6 integrin in PDAC.
机译:已知胰腺导管腺癌(PDAC)是最致死的癌症之一。由于大多数患者被诊断为晚期阶段,因此强烈希望在疾病进展的早期阶段进行PDAC的检测方法。整合素α(v)β6是早期PDAC检测的有希望的靶标,因为其表达在癌前变化期间增加。本研究旨在开发用于靶向α(v)β6整合蛋白阳性Pdac的正电子发射断层扫描(PET)的成像探针。我们选择了A20FMDV2肽,其特异性地结合到α-β6整合蛋白,作为探针支架,GA-68作为放射性同位素。 a20fmdv2肽以前没有用ga-68标记。将半胱氨酸残基引入探针的N-末端,在马来酰亚胺-NOTA(MAL-NOTA)螯合物的特异性缀合。在半胱氨酸和A20FMDV2序列中也引入不同数量的甘氨酸残基作为间隔物,以减少对αVβ6整联蛋白的结合探针上的MAL-NOTA的空间阻力。体外,竞争性结合测定显示含有6-甘氨酸接头([GA-NAT] CG6和[GA-NAT] AC-CG6)的探针对αVβ6整联蛋白表现出高亲和力。可以通过GA-67/68标记这两个探针,高放射化学产率(> 50%)和纯度(> 98%)。在生物分布分析中,[Ga-67] AC-CG6显示出肿瘤积聚,更快的血液清除,胰腺周围的胰腺中的较低积累,而不是[GA-67] CG6。通过PET成像用[GA-68] AC-CG6清楚地可视化α(v)β6整合蛋白阳性异种移植物。 [Ga-68] AC-CG6的纳米型分布与免疫组织化学检测的α(v)β6整联蛋白阳性区域一致。因此,[Ga-68] AC-CG6是用于在PDAC中的α(v)β6整联蛋白的成像的有用肽探针。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号